Episode
Relapsed/Refractory Multiple Myeloma — ASH 2025 Review
- Podcast
- Hematologic Oncology Update
- Published
- Jan 16, 2026
- Duration seconds
- 3666
- Processing state
not_requested- Canonical source
- https://hematologic-oncology.captivate.fm/episode/5603-ashrrmm25
Actions
POST https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/relapsed-refractory-multiple-myeloma-ash-2025-review/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/hematologic-oncology-update-916423/relapsed-refractory-multiple-myeloma-ash-2025-review.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Dr Sagar Lonial from Winship Cancer Institute of Emory University in Atlanta, Georgia, and Dr María-Victoria Mateos from the University Hospital of Salamanca in Salamanca, Spain, discuss cases of relapsed/refractory multiple myeloma and recentresearch findings from the 2025 ASH Annual Meeting. CME information and select publications here .